Alejandro Antalich - Moolec Science Chief Officer
| MLEC Stock | 3.09 0.11 3.44% |
Executive
Alejandro Antalich is Chief Officer of Moolec Science SA
| Age | 52 |
| Address | , United Kingdom |
| Phone | 352 26 49 65 65 |
| Web | https://moolecscience.com |
Moolec Science Management Efficiency
The company has return on total asset (ROA) of (0.2169) % which means that it has lost $0.2169 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.7468) %, meaning that it created substantial loss on money invested by shareholders. Moolec Science's management efficiency ratios could be used to measure how well Moolec Science manages its routine affairs as well as how well it operates its assets and liabilities. As of August 5, 2025, Return On Tangible Assets is expected to decline to -0.35. In addition to that, Return On Capital Employed is expected to decline to -0.32. At present, Moolec Science's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 12.3 M, whereas Net Tangible Assets are projected to grow to (2.6 M).Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Sam Davis | Bridger Aerospace Group | 40 | |
| Joseph Cappello | Genelux Common | 68 | |
| Lourie Zak | Genelux Common | 62 | |
| Sean JD | Genelux Common | 56 | |
| Eric CPA | Bridger Aerospace Group | 54 | |
| John Saunders | Bridger Aerospace Group | N/A | |
| Whye Tay | EUDA Health Holdings | N/A | |
| Pr MD | Genelux Common | 80 | |
| Eric JD | Genelux Common | 54 | |
| Khullani JD | Cardio Diagnostics Holdings | 41 | |
| John Ang | EUDA Health Holdings | 52 | |
| Esq JD | Cardio Diagnostics Holdings | 60 | |
| Ralph BSc | Genelux Common | 70 | |
| Yong Yu | Genelux Common | 54 | |
| Yew CPA | EUDA Health Holdings | 56 | |
Management Performance
| Return On Equity | -1.75 | ||||
| Return On Asset | -0.22 |
Moolec Science SA Leadership Team
Elected by the shareholders, the Moolec Science's board of directors comprises two types of representatives: Moolec Science inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Moolec. The board's role is to monitor Moolec Science's management team and ensure that shareholders' interests are well served. Moolec Science's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Moolec Science's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alejandro Antalich, Chief Officer | ||
| Oscar Betancor, Executive Director | ||
| Florencia Bottero, Corporate Board | ||
| Martin Salinas, CoFounder Technology | ||
| Agustin Falus, Global Controller | ||
| Jose MBA, Chief Officer | ||
| Gaston MBA, CEO CoFounder | ||
| Amit Dhingra, Chief Officer | ||
| Henk Hoogenkamp, CoFounder Officer | ||
| Gloria Estrada, Executive Director | ||
| Catalina BA, Chief Sustainability |
Moolec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Moolec Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.75 | ||||
| Return On Asset | -0.22 | ||||
| Current Valuation | 32.96 M | ||||
| Shares Outstanding | 4 M | ||||
| Shares Owned By Insiders | 27.12 % | ||||
| Shares Owned By Institutions | 0.11 % | ||||
| Number Of Shares Shorted | 4.66 K | ||||
| Price To Book | 4.58 X | ||||
| Price To Sales | 1.57 X | ||||
| Revenue | 5.63 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Moolec Science SA is a strong investment it is important to analyze Moolec Science's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Moolec Science's future performance. For an informed investment choice regarding Moolec Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moolec Science SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moolec Science. If investors know Moolec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moolec Science listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.10) | Revenue Per Share | Quarterly Revenue Growth 9.483 | Return On Assets | Return On Equity |
The market value of Moolec Science SA is measured differently than its book value, which is the value of Moolec that is recorded on the company's balance sheet. Investors also form their own opinion of Moolec Science's value that differs from its market value or its book value, called intrinsic value, which is Moolec Science's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moolec Science's market value can be influenced by many factors that don't directly affect Moolec Science's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moolec Science's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moolec Science is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moolec Science's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.